Hostname: page-component-74656f9884-8rzl6 Total loading time: 0 Render date: 2026-11-05T23:34:04.096Z Has data issue: false hasContentIssue false

Progress and challenges in clay-based haemostatic materials

Published online by Cambridge University Press:  15 June 2026

Shuiqing Zhou
Affiliation:
Department of Materials Science and Engineering, College of Chemistry and Materials Science, Jinan University, Guangzhou, P.R. China
Xiangyu Chen
Affiliation:
Department of Materials Science and Engineering, College of Chemistry and Materials Science, Jinan University, Guangzhou, P.R. China
Mingxian Liu*
Affiliation:
Department of Materials Science and Engineering, College of Chemistry and Materials Science, Jinan University, Guangzhou, P.R. China
*
Corresponding author: Mingxian Liu; Email: liumx@jnu.edu.cn
Rights & Permissions [Opens in a new window]

Abstract

Uncontrolled acute haemorrhage remains a leading cause of death in emergency situations such as warfare, traffic accidents and surgical procedures. Current clinical haemostatic materials have numerous limitations such as allowing high levels of blood loss, having slow clotting rates, being non-degradable and being difficult to fit onto complicated wounds. Due to their high water absorption, surface negative charge, ion-exchange capacity, abundant availability and good biocompatibility, clay minerals show promise as haemostatic materials. Herein, we review recent advances in the field of haemostasis involving clay minerals including kaolinite, zeolite, halloysite, montmorillonite and palygorskite, among others. The fabrication methods and performance in vitro and in vivo for these wound dressings are introduced, and their haemostatic properties are correlated with the chemical composition and microstructure of the clays. Then, the haemostatic mechanisms of the clays are discussed. To satisfy the needs of diverse clinical applications, the development of high-performance and functional haemostatic materials based on clay minerals should be conducted via the engineered design of these wound-healing materials. In the future, the integration of multiple functions, including haemostasis, antibacterial activity, promotion of tissue repair/regeneration, high biocompatibility, degradability, ability to fit complicated wound shapes and low cost, will enable the development of next-generation wound dressings based on clay minerals.

Information

Type
Review Article
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Mineralogical Society of the United Kingdom and Ireland.
Figure 0

Figure 1. Schematic illustration of different structures of various clay minerals.Figure 1 long description.

Figure 1

Figure 2. Kaol-based products used for haemostasis. (a) Crystal structure of Kaol, adapted under the terms of the Creative Commons CC BY licence (Wu et al., 2023); transmission electron microscopy image and haemostatic mechanism of Kaol, adapted with permission from the published work (Long et al., 2019). Copyright 2019 Elsevier B.V. (b) Bird nest-inspired fluffy Kaol sponges for haemostasis and wound healing, adapted with permission from the published work (Dong et al., 2025). Copyright 2025 Elsevier B.V. CA = cellulose acetate; CG = Combat Gauze; Cur = curcumin; KCFS = kaolin/cellulose acetate fibrous sponge; PVA = poly(vinyl alcohol); RH = relative humidity. (c) Multi-crosslinking Kaol/oxidized cellulose hydrogel with robust properties for emergency haemostasis, adapted with permission from the published work (Zhao et al., 2025). Copyright 2024 Elsevier B.V. AA = acrylic acid; APS = ammonium persulfate; KPON = kaolin/OMCC-NHS/PAA hydrogel; MBA = N,N’-methylenebisacrylamide; OMCC-NHS = N-hydroxysuccinimide-grafted oxidized microcrystalline cellulose; PAA = poly(acrylic acid). (d) Kaol–Ze composite: a synergistic haemostat for effective haemorrhage control, adapted with permission from the published work (Wang et al., 2024a). Copyright 2024 American Chemical Society. CG = Combat Gauze; KZG = kaolin-modified zeolite gauze; TF = tissue factor; ZG = zeolite gauze.Figure 2 long description.

Figure 2

Figure 3. Ze-based products used for haemostasis. (a) Crystal structure of Ze, adapted with permission from the published work (Tong et al., 2025). Copyright 2025 Elsevier B.V. Transmission electron microscopy image and haemostatic mechanism of Ze, adapted with permission from the published work (Shang et al., 2021). Copyright 2021 Springer Nature. (b) Composite haemostat spray staunches post-surgical bleeding and ameliorates bacteria-induced inflammation to expedite wound healing, adapted with permission from the published work (Xu et al., 2023b). Copyright 2023 American Chemical Society. Ag-bZ-F/T = silver-loaded beta-zeolite combined with fibrinogen and thrombin; ROS = reactive oxygen species. (c) A bio-inorganic hybrid haemostatic gauze for haemorrhage control within the ‘platinum ten minutes’, adapted with permission from the published work (Yu et al., 2022). Copyright 2022 American Chemical Society. BZG = bio-zeolite gauze; CG = Combat Gauze; ns = non-significant; ZG = zeolite gauze; * and ** denote statistical significance at p < 0.05 and p < 0.01, respectively. (d) Ze-anchored regenerated cellulose aerogel for efficient and biosafe haemostasis, adapted with permission from the published work (Jin et al., 2025). Copyright 2025 Elsevier B.V. CM = first 10 min immediately after severe traumatic hemorrhage. (e) A flexible mesoporous Ze–cotton hybrid haemostat, adapted under the terms of the Creative Commons CC BY licence (Yu et al., 2019). CG = Combat Gauze; CHA = chabazite-type; FAU = faujasite; mCHA-C = mesoporous chabazite-type/zeolite/cotton hybrid.Figure 3 long description.

Figure 3

Figure 4. HNT-based products used for haemostasis. (a) Morphological characterization (photograph, transmission electron microscopy and scanning electron microscopy images), adapted with permission from the published work (Feng et al., 2023). Copyright 2023 John Wiley and Sons. Crystal structure, adapted with permission from the published work (Feng et al., 2024), Copyright 2024 American Chemical Society. Haemostatic mechanism of HNTs, adapted with permission from the published work (Feng et al., 2022), Copyright 2022 Elsevier B.V. PET = poly(ethylene terephthalate). (b) 3D-printed HNT/chitosan hydrogel for haemostasis and infected wound healing, adapted under the terms of the Creative Commons CC BY licence (Chen et al., 2025d). CS = chitosan; Lev = levofloxacin. (c) HNT-triggered self-gelling yam microparticles for wet tissue adhesion and instant haemostasis, adapted with permission from the published work (Xu et al., 2025b). Copyright 2025 American Chemical Society. (d) Au@HNT/chitin composite hydrogel with antibacterial and haemostatic activities for wound healing, adapted under the terms of the Creative Commons CC BY licence (Zhao et al., 2023a). NIR = near-infrared; OAc = oleic acid; OAm = oleylamine.Figure 4 long description.

Figure 4

Figure 5. MMT-based products used for haemostasis. (a) Transmission electron microscopy image and scanning electron microscopy image, adapted with permission from the published work (Paluszkiewicz et al., 2011). Copyright 2011 Elsevier B.V. Crystal structure of MMT (Chen et al., 2025c), adapted under the terms of the Creative Commons CC BY licence. (b) MMT/agarose 3D network gelatin sponge for wound healing with haemostatic and durable antibacterial properties, adapted with permission from the published work (Zhang et al., 2023). Copyright 2023 American Chemical Society. AG = agarose gel sponge; AMA = Ag-Mt/agarose composite gel sponge; CMD = commercial medical dressing; Mt = montmorillonite; ns = non-significant; *, ** and **** denote statistical significance at p < 0.05, p < 0.01 and p < 0.0001, respectively. (c) Hydrogel loaded with exfoliated MMT using anti-inflammatory Lycium barbarum polysaccharides for advanced wound dressing, adapted with permission from the published work (Shi et al., 2022). Copyright 2022 Elsevier B.V. A-MMT = polysaccharide (LBP)-functionalized ultrathin MMT nanosheets; LBP = polysaccharides extracted from Lycium barbarum L.; P-L-MMT = PVA hydrogel loaded with L-MMT; PVA = poly(vinyl alcohol). (d) Water-triggered shape memory cellulose/alginate/MMT composite sponge for rapid haemostasis, adapted with permission from the published work (Liu et al., 2024c). Copyright 2024 Elsevier B.V. CN = carboxylated cellulose; SA = sodium alginate. (e) Quaternized chitin/egg white protein/MMT composite sponge with antibacterial and haemostatic effects for wound healing, adapted with permission from the published work (Yang et al., 2022). Copyright 2022 Elsevier B.V. EMQS = egg white protein/quaternized chitin derivative/MMT composite sponge; MRSA = methicillin-resistant Staphylococcus aureus.Figure 5 long description.

Figure 5

Figure 6. Pal-based products used for haemostasis. (a) Photograph, transmission electron microscopy image, crystal structure and haemostatic mechanism of Pal, adapted with permission from the published work (Yang et al., 2024c). Copyright 2024 IOP Publishing Ltd. R-Pal = raw Pal. (b) Anti-infective and pro-coagulant chitosan composite sponge with shape memory for haemostasis in multi-tissue defects, adapted with permission from the published work (Du et al., 2025a). Copyright 2025 Elsevier B.V. DMP = disuccinimide carbonate-modified polyethylene glycol; QPC = quaternized and phosphated chitosan. (c) Lauric acid-modified quaternized chitosan and Pal-reinforced self-elastic chitosan sponge for non-compressible haemorrhage and wound healing, adapted with permission from the published work (Du et al., 2025b). Copyright 2025 Elsevier B.V. CS = chitosan; LQC = lauric acid-modified quaternized chitosan. (d) Antibacterial and antioxidant adherent sponge for arterial bleeding control via gallic acid-mediated fibrous clay assembly in collagen, adapted with permission from the published work (Guo et al., 2025). Copyright 2025 American Chemical Society. Ca-Pal-GA = Ca2+-loaded Pal assembled with gallic acid; COL = collagen; EDC/NHS = 1-ethyl-3-(3-dimethylaminopropy)carbodimide/N-hydroxysuccinimide.Figure 6 long description.

Figure 6

Figure 7. Structures, forms and haemostatic mechanisms of mineral-based haemostatic materials.Figure 7 long description.